4//SEC Filing
EPSTEIN ROBERT S 4
Accession 0001209191-23-035049
CIK 0001434316other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 4:08 PM ET
Size
5.6 KB
Accession
0001209191-23-035049
Insider Transaction Report
Form 4
EPSTEIN ROBERT S
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-06+40,000→ 40,000 totalExercise: $5.52Exp: 2033-06-06→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]This transaction represents a grant of options pursuant to the terms of the Issuer's Amended and Restated Non-Employee Director Compensation Policy which provides for annual equity grants to the Issuer's non-employee directors on the date of the Issuer's Annual Meeting of Stockholders.
- [F2]The shares subject to this option shall vest and become exercisable on the earlier of (i) June 6, 2024 or (ii) the date of the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors.
Documents
Issuer
FATE THERAPEUTICS INC
CIK 0001434316
Entity typeother
Related Parties
1- filerCIK 0001252004
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 4:08 PM ET
- Size
- 5.6 KB